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Background: Transgelin2, one of cytoskeletal actin binding proteins has recently been suggested to be involved in
the formation of immune synapses. Although detailed function of transgelin2 is largely unknown, interactions
between transgelin2 and actin appear to be important in regulating cellular functions of transgelin2. Because
protein phosphorylation can change ability to interact with other proteins, comprehensive phosphorylation analysis
of transgelin2 will be helpful in understanding its functional mechanisms.
Results: Here, a specific protein label-free quantitative phosphorylation analysis method combining immuno-precipitation,
IMAC phosphopeptide enrichment technique and label-free relative quantification analysis was used to monitor the
phosphorylation changes of transgelin2 overexpressed in Jurkat T cells under protein kinase C (PKC) and protein kinase A
(PKA) activation conditions, two representative intracellular signalling pathways of immune cell activation and homeostasis.
A total of six serine/threonine phosphorylation sites were identified including threonine-84, a novel phosphorylation site.
Notably, distinct phosphorylation patterns of transgelin2 under the two kinase activation conditions were observed. Most
phosphorylation sites showing specific kinase-dependent phosphorylation changes were discretely located in two
previously characterized actin-binding regions: actin-binding site (ABS) and calponin repeat domain (CNR). PKC
activation increased phosphorylation of threonine-180 and serine-185 in the CNR, and PKA activation increased
phosphorylation of serine-163 in the ABS.
Conclusions: Multiple actin-binding regions of transgelin2 participate to accomplish its full actin-binding capability, and
the actin-binding affinity of each actin-binding region appears to be modulated by specific kinase-dependent
phosphorylation changes. Accordingly, different actin-binding properties or cellular functions of transgelin2 may
result from distinct intracellular signalling events under immune response activation or homeostasis conditions.
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Transgelin2 was characterized as a smooth muscle cyto-
skeletal protein and subsequently classified into the calpo-
nin family. Although the detailed function of transgelin2 is
largely unknown, co-localization with F-actin cytoskeleton
in the cytoplasm has been recently reported [1]. Close ho-
mologues of transgelin2 such as transgelin/SM22α and
calponin1 have been studied much more extensively than
transgelin2 and possess actin-binding properties [2-6].
Functional studies of transgelin/SM22α and calponin1
have shown that these transgelin2 homologues are in-
volved in actin cross-linking/ gelling process. These obser-
vations suggest that transgelin2 may also participate in the
regulation of actin cytoskeleton dynamics. Because several
proteomics studies have suggested transgelin2 as a poten-
tial biomarker candidate of tumorigenesis and metastasis,
the functional roles of transgelin2 have predominantly
been investigated using various cancer cell lines and tissue
samples [7-9]. Interestingly, research groups have reported
somewhat contradictory results regarding the expression
levels and cellular functions of transgelin2. Both oncogenic
and tumor suppressive effects of transgelin2 have been ob-
served depending on the types of cancer cell lines and tis-
sue samples investigated. For example, Zhang et al. and
Rho et al. reported the increased expression of transgelin2
in colorectal cancer and lung adenocarcinoma patient tis-
sue samples, respectively [7,9]. Elsner et al. observed
down-regulated transgelin2 expression in Barrett’s adeno-
carcinoma patient tissue samples [10]. Regarding cancer
cell lines, Yoshino et al. reported an oncogenic function of
transgelin2 in bladder cancer cell lines [11]. These onco-
genic functions of transgelin2 were further confirmed in
other types of cancer cells, including lung squamous car-
cinoma cells, renal carcinoma cells, and head and neck
squamous carcinoma cells by the same research group
[12-15]. In contrast, tumor-suppressive function and anti-
angiogenesis effects of transgelin2 were observed in hepato-
cyte cells and endothelial cells, respectively [1,16]. Because
there is no simple explanation for these contradictory re-
sults, additional properties in addition to the changes in the
expression level of transgelin2 must exist. Recently, Leung
et al. reported transgelin2 as one of the downstream signal
transduction molecules of PFTK1 protein kinase in the
control of liver cancer cell motility [16]. They suggested
that the phosphorylation of serine-83 and serine-163 of
transgelin2 plays an important role in controlling can-
cer cell invasion and motility. Although the connection
between specific amino acid phosphorylation and the
tumor suppressor function of transgelin2 was established
by site-directed mutagenesis (phosphorylation-mimetic and
-defective) in their study, evidence for the actual phosphor-
ylation of these two amino acid residues was not provided.
A more focused and comprehensive protein quantitative
phosphorylation analysis that can monitor phosphorylationchanges of individual transgelin2 phosphorylation sites
under different conditions is necessary to consolidate the
functional relevance of transgelin2 phosphorylation. A
quantitative phosphorylation analysis focusing on transge-
lin2 has not been previously conducted; however, several
large-scale quantitative phosphoproteomics studies have
reported phosphorylation level changes of transgelin2 in
immune cells [17-19]. Because these studies investigated
system-wide signal transduction pathways in different
types of T cells, only one or two phosphorylation sites of
transgelin2 were quantitatively analysed. To reveal the
functional significance of transgelin2 phosphorylation
events, comprehensive transgelin2 quantitative phosphor-
ylation analysis under more specific kinase activation con-
ditions is required.
In this study, a specific protein label free quantitative
phosphorylation analysis method combining immuno-
precipitation, IMAC phosphopeptide enrichment technique
and mass spectrometric label-free relative quantitation was
used to achieve comprehensive phosphorylation analysis of
transgelin2 under any given conditions. While only two
phosphorylation sites of transgelin2 were investigated in
large-scale quantitative phosphorylation analyses of im-
mune cells, five phosphorylation sites of transgelin2 were
quantitatively analysed in this study. Reproducibility of the
entire sample preparation procedure was first systematically
evaluated. Our method was then used to investigate the
phosphorylation changes of transgelin2 overexpressed in
Jurkat T cells under two different kinase activation condi-
tions. Jurkat T cells are a well-characterized model for
studying immune response signaling. Protein kinase A
(PKA) and protein kinase C (PKC) activation conditions
were chosen in this study as the two representative serine/
threonine kinase cascades of immune response homeostasis
and activation, respectively [20,21]. We hypothesized that
the serine/threonine phosphorylation events of transgelin2
are discretely modulated by specific kinases that were acti-
vated under immune response activation or homeostasis
conditions, resulting in two distinctive transgelin2 func-
tions. To our knowledge, the functional relevance of trans-
gelin2 phosphorylation in immune cell responses has not
been described previously.
Results
The phosphatase inhibitory effects of calyculin A
Conventional phosphatase inhibitor treatments of the
cell lysates such as phosphatase inhibitor cocktails did
not effectively improve the identification of transgelin2
Ser/Thr phosphorylation sites. Only one or two phos-
phorylation sites were typically identified. To increase
the number of transgelin2 phosphorylation sites identi-
fied in the quantitative phosphorylation analysis, various
phosphatase inhibitors such as calyculin A and okadaic
acid were tested. Among the phosphatase inhibitors
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the most significant changes in terms of the total num-
bers of identified phosphorylation sites and phosphopep-
tides. To show the phosphatase inhibitory effects of
calyculin A, Jurkat T cells overexpressing GFP-tagged
transgelin2 were treated with calyculin A for 30 min,
okadaic acid for 30 min or untreated prior to cell har-
vest. These three cell samples were lysed separately with
lysis buffers containing conventional phosphatase inhibi-
tors, followed by immuno-precipitations with anti-GFP
antibodies. The immuno-purified GFP-tagged transge-
lin2 samples were then subjected to SDS-PAGE and the
resulting SDS-PAGE gel was sequentially stained with
Pro-Q Diamond and Coomassie. The Coomassie stain-
ing results showed one major protein band that matched
the molecular weight of GFP-tagged transgelin2, and the
intensities of this protein band were not noticeably dif-
ferent among the untreated and two phosphatase-treated
conditions (Figure 1A). In contrast, the Pro-Q Diamond
staining results indicated significantly higher phosphor-
ylation levels of transgelin2 in calyculin A-treated sam-
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Figure 1 Calyculin A treatment effects in the phosphorylation analysi
results of GFP tagged transgelin2 following SDS-PAGE separation (A and Bthe GFP-tagged transgelin2 in calyculin A-treated sam-
ple was further confirmed by micro RPLC-MS/MS ana-
lysis. The number of unique phosphopeptide identified
was increased from 4 to 9 and a total of 6 phosphoryl-
ation sites were identified in the samples with the caly-
culin A treatment. The total number of MS/MS spectra
assigned to phosphopeptides was increased by more
than four-fold from 12 to 56 through the use of the caly-
culin A treatment (Figure 1C). Among the phosphoryl-
ation sites identified in the calyculin A-treated sample,
threonine-84 has not been previously identified by mass
spectrometry. MS/MS spectrum of the phosphopeptide
containing threonine-84 was manually validated, and the
results are shown in Additional file 1: Figure S1.
Reproducibility of a specific protein label-free quantitative
phosphorylation analysis
To demonstrate our reproducible phosphopeptide sam-
ple preparation procedure, three aliquots of cell lysates
containing 5 mg proteins were independently subjected
to immuno-precipitation, SDS-PAGE, in-gel digestion,



















































s of transgelin2. ProQ-Diamond and Coomassie sequential staining
), and micro RPLC-MS/MS analysis results (C).
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from three independent experiments. Several phospho-
peptides that were commonly identified in all three in-
dependent experiments are not included in Table 1
because the signal-to-noise ratios of the selected ion
chromatograms were too low for peak area comparison.
Although the peak areas of these phosphopeptides dif-
fered by more than two orders of magnitude, the rela-
tive standard deviations of each phosphopeptide ranged
from 1.6 to 20.4%, with an average relative standard de-
viation of 9.5%. Because most label-free quantitative
phosphorylation analysis studies employ peak area
normalization using co-injected phosphopeptide stan-
dards or non-phosphopeptides in the sample, the ef-
fects of phosphopeptide peak area normalization were
tested using co-added bovine alpha casein tryptic digest
peptides. The phosphopeptide peak area normalization
results are shown in Additional file 2: Table S1. There
were no significant differences observed before and
after phosphopeptide peak area normalizations, as the
average relative standard deviations was 10.0%. The lin-
earity of our quantitative phosphorylation analysis was
also tested using a standard protein, bovine alpha ca-
sein. Various concentrations of alpha casein samples
ranging from 0.1 to 1.0 μg were added to the SDS-
PAGE separation (Additional file 3: Figure S2A). Three
independent experiments were performed and the peak
areas of the individual alpha casein phosphopeptides
were plotted against the loaded amounts of alpha ca-
sein (Additional file 3: Figure S2B, C, D). A linear re-
sponse of peak area measurements was observed in the
concentration range tested for all three phosphopep-
tides and the R2 values ranged from 0.9851 to 0.9982.Table 1 Reproducibility of specific protein label-free quantita
experiments




GPAYGLpSR(+2) 11th 62.48 × E06
GPAYGLpSREVQQK(+2) 11th 27.16 × E06
IQASpTM(ox)AFK(+2) 84th 2.41 × E06
NFpSDNQLQEGK(+2) 163th 168.18 × E06
NFpSDNQLQEGK(+1) 163th 3.46 × E06
NVIGLQMGpTNR(+2) 180th 1.94 × E06
NVIGLQM(ox)GpTNR(+2) 180th 1.97 × E06
GApSQAGMTGYGMPR(+2) 185th 62.43 × E06
GApSQAGM(ox)TGYGMPR(+2) 185th 73.58 × E06
GApSQAGMTGYGM(ox)PR(+2) 185th 43.92 × E06
GApSQAGM(ox)TGYGM(ox)PR(+2) 185th 72.91 × E06
Three independent label-free quantitative phosphorylation analyses of transgelin2 wer
Selected ion chromatograms of phosphopeptides were constructed from three micro RPQuantitative phosphorylation analysis of transgelin2
under PKC and PKA activation conditions
Our label-free quantitative phosphorylation analysis
method was then used to investigate the phosphoryl-
ation level changes of GFP-tagged transgelin2 overex-
pressed in Jurkat T cells under PKC activation
conditions. The most significant phosphorylation level
change was observed with serine-185, in which the
phosphorylation increased by more than two-fold. A
manually validated MS/MS spectrum and selected ion
chromatograms of the phosphopeptide containing
serine-185 with or without PMA treatment are shown
in Figure 2. Other phosphorylation sites showing sig-
nificant phosphorylation level changes included serine-
11 and threonine-180 (Additional file 4: Figure S3 and
Additional file 5: Figure S4). Additionally, phosphopep-
tides containing methionine residue(s) were identified
as discrete phosphopeptides, depending on the num-
bers and locations of oxidized methionine. For ex-
ample, serine-185 co-localized with two methionine
residues in the same tryptic digest peptide was identi-
fied in four different phosphopeptides. Two isobaric
phosphopeptides, 183GAS*QAGMoxTGYGMPR196 and
183GAS*QAGMTGYGMoxPR196, whose only difference
consisted of the location of the oxidized methionine,
were clearly separated in the RPLC separation and un-
ambiguously identified (Figure 3A and B). Finally, selected
ion chromatograms of the phosphopeptides containing
serine-185 with two oxidized methionines are shown in
Figure 3C and D. The phosphorylation of transgelin2 under
the PKA activation condition was also investigated by our
quantitative phosphorylation analysis method. Although






60.18 × E06 71.39 × E06 64.68 × E06 (0.092)
27.77 × E06 26.94 × E06 27.29 × E06 (0.016)
2.72 × E06 2.80 × E06 2.64 × E06 (0.078)
193.05 × E06 186.64 × E06 182.62 × E06 (0.071)
4.93 × E06 4.13 × E06 4.17 × E06 (0.176)
1.46 × E06 1.96 × E06 1.79 × E06 (0.158)
2.52 × E06 2.38 × E06 2.29 × E06 (0.125)
55.27 × E06 61.93 × E06 59.88 × E06 (0.067)
80.29 × E06 77.44 × E06 77.10 × E06 (0.044)
43.28 × E06 42.38 × E06 43.19 × E06 (0.018)
82.53 × E06 107.47 × E06 87.64 × E06 (0.204)
e carried out to show the reproducibility of entire sample preparation procedure.
LC-MS/MS analyses, and peak areas were plotted.
Figure 2 PKC-dependent phosphorylation changes of transgelin2 serine-185. Selected ion chromatograms of a phosphopeptide containing
serine-185 under no activation (A) and PKC activation (B) conditions. Manually assigned MS/MS spectrum of phosphopeptide containing
serine-185 (C).
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PKC activation, a moderate level of phosphorylation
change (~36% increase) was observed only at serine-163
(Additional file 6: Figure S5). To increase the confi-
dence level of our transgelin2 quantitative phosphoryl-
ation analysis results, the PKA, PKC and no activation
condition experiments were independently performed
three times. The peak areas of the individual phospho-
peptides from the three independent experiments under
the above two kinase activation conditions were calcu-
lated and plotted in terms of the peak area ratios com-
pared with the no activation condition experiments
(Figure 4 and Additional file 7: Figure S6). The prefer-
ential phosphorylation sites of transgelin2 under the
PKA and PKC activation conditions appeared to vary.
Serine-11, threonine-180 and serine-185 were respon-
sive solely to PKC activation, whereas serine-163 is re-
sponsive to PKA activation.Discussion
Large-scale label-free quantitative phosphorylation ana-
lyses using phosphopeptide enrichment techniques have
been demonstrated by various research groups; however,
specific protein label-free quantitative phosphorylation
analyses that combine immuno-precipitation SDS-PAGE
separation, in-gel digestion and phosphopeptide enrich-
ment techniques have not frequently been reported. Specif-
ically, the reproducibility of the specific protein label-free
quantitative phosphorylation analysis approach has not
been systematically studied until now, which can be attrib-
uted to the somewhat laborious and time-consuming sam-
ple preparation procedure. Accordingly, most specific
protein quantitative phosphorylation analysis studies have
avoided using phosphopeptide enrichment techniques fol-
lowing the target protein immuno-precipitation or have
employed isotope-labeling strategies to monitor the phos-
phorylation level changes under different conditions




















NL: 4.97 × E6
*Retention Time: 44.8 min
Peak Area: 40.85 × E6
**Retention Time: 49.2 min
Peak Area: 66.37 × E6
No activation
NL: 4.97 × E6
*Retention Time: 45.0 min
Peak Area: 145.96 × E6
**Retention Time: 47.7 min
Peak Area: 288.12 × E6
PKC activation
























NL: 6.34 × E6
Retention Time: 35.8 min
Peak Area: 73.17 × E6
No activation
NL: 6.34 × E6
Retention Time: 36.0 min
Peak Area: 337.90 × E6
PKC activation










































Figure 3 PKC-dependent phosphorylation changes of transgelin2 serine-185. Selected ion chromatograms of two isobaric
phosphopeptides containing one oxidized methionine (183GApSQAGMoxTGYGMPR196 and 183GApSQAGMTGYGMoxPR196) (A and B) and the same
sequence phosphopeptide with two oxidized methionines under no activation and PKC activation condition (C and D). * denotes
183GApSQAGMTGYGMoxPR196 and ** denotes 183GApSQAGMoxTGYGMPR196.
Jang et al. Proteome Science  (2015) 13:14 Page 6 of 10[22-25]. In this study, we demonstrated that the entire sam-
ple preparation procedure including immuno-precipitation,
SDS-PAGE separation, in-gel digestion and IMAC phos-
phopeptide enrichment could be conducted in a reprodu-
cible manner for the subsequent label-free phosphopeptide
quantification analysis. Normalization of the phosphopep-
tide peak areas using the internal standard bovine alpha ca-
sein phosphopeptide was expected to lower the level of
peak area deviation that resulted from variable phospho-
peptide enrichment efficiencies in the three independent
experiments; however, a similar degree of peak area devia-
tions was observed. The level of peak area deviation ob-
served in this study (average relative standard deviation of
9.5%) is comparable to previously reported isotope labeling
quantitative analysis results using SILAC, iTRAQ, and
TMT techniques [26-28]. The relatively low peak area devi-
ations in the repeated experiments suggested a high level of
reproducibility, which is crucial for successful label-free
quantitative phosphorylation analyses.In this study, distinct phosphorylation changes of
transgelin2 in Jurkat T cells under PKC and PKA activa-
tion conditions was monitored using our specific protein
label-free quantitative phosphorylation analysis. The
quantitative phosphorylation analysis of transgelin2
under these two conditions was expected to reveal the
phosphorylation dynamics of transgelin2 during immune
response activation and homeostasis. A total of six trans-
gelin2 phosphorylation sites were identified in this study,
and four phosphorylation sites exhibited specific kinase-
dependent phosphorylation changes. Among the three
phosphorylation sites showing PKC-dependent phos-
phorylation changes, threonine-180 and serine-185 are
located in the calponin repeat domain, of which a
physiological role has not yet been well described. How-
ever, Sugaya et al. reported that the calponin repeat do-
main 1 (CNR1: aa164-203) of smooth muscle calponin1
(CNN1) is more important with regard to the actin-











































Figure 4 Label-free relative quantitative phosphorylation analysis results of transgelin2 phosphorylation sites under PKA and PKC
activation conditions. The peak areas of the individual phosphopeptides containing ser-11 (A), threonine-84 (B), serine-163 (C) and threonine-180 (D)
from the three independent experiments under the above two kinase activation conditions were calculated and plotted in terms of the peak area ratios
compared with the no activation condition experiments. * denotes the level of statistically significant difference in three independent sets of
experiments. (p < 0.05).
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phosphorylation of serine-175 located in CNR1 was me-
diated by PKC, and the phosphorylation status of this
residue lowered the actin-binding of calponin1. Transge-
lin2 is very similar to calponin1 in terms of its tissue-
specific expression pattern, actin-binding properties and
structural domain compositions. Transgelin2 contains
one calponin homology domain and one calponin repeat
domain, whereas calponin1 contains two additional cal-
ponin repeat domains in the C-terminal. Although these
two proteins share a sequence homology of 43%, all of
the phosphorylation sites identified in this study except
serine-163 are conserved and located in the same pos-
ition in the sequence alignment analysis (Additional file
8: Figure S7). Serine-175 of CNN1, a PKC phosphoryl-
ation site, is aligned with serine-185 of transgelin2.
PKC-dependent phosphorylation changes of threonine-
180 have not been reported elsewhere. We hypothesize
that the substantial phosphorylation changes of threo-
nine 180th and serine 185th in CNR under PKC activa-
tion condition can greatly alter the actin-binding
properties of transgelin2. Serine-11, which displayed
PKC activation-dependent phosphorylation changes,
does not belong to any well-defined structural domains.The potential functions of this phosphorylation site
with regard to the actin-binding property of transgelin2
cannot be ignored; however, because the phosphoryl-
ation level was significantly increased. Further studies
are required to investigate the functional significance of
serine-11 phosphorylation on the actin binding of trans-
gelin2. Notably, only one phosphorylation site, serine-
163 showed PKA activation-dependent phosphorylation
changes. Although the level of phosphorylation change
for serine-163 was not as significant as expected, statisti-
cally significant differences (p < 0.05) were observed in
three independent experiments. Serine-163 was positioned
in the previously reported actin-binding site (ABS) of two
close homologs of transgelin2, CNN1 and transgelin/
SM22α.(CNN1: aa142-163, SM22α: aa151-166) The func-
tional roles of this ABS with regard to actin-binding have
been demonstrated by several domain deletion mutagenesis
experiments with CNN1 and SM22α [2,5]. Additionally,
the serine-163 phosphorylation-dependent actin-binding
ability of transgelin2 was suggested by Leung et al [16].
Therefore, PKA-dependent serine-163 phosphorylation in
the ABS may also modulate the actin binding of transge-
lin2. Taken together, multiple actin-binding regions of
transgelin2 participate to accomplish its full actin-binding
Jang et al. Proteome Science  (2015) 13:14 Page 8 of 10capability, and the actin-binding affinity of each actin-
binding region appears to be modulated by specific kinase-
dependent phosphorylation changes. Accordingly, different
actin-binding properties or conflicting cellular functions of
transgelin2 may result from distinct intracellular signaling
events under immune response activation or homeostasis
conditions.
Conclusions
Our specific protein label-free phosphorylation quantita-
tive analysis revealed distinct phosphorylation changes of
transgelin2 in Jurkat T cell lines under the PKC and PKA
activation conditions, which are comparable to immune
cell activation and homeostasis conditions, respectively.
Among the six transgelin2 phosphorylation sites identified
in this study, four phosphorylation sites were located in
three potential actin-binding regions: the ABS, the calpo-
nin homology domain (CH) and the CNR1. Notably, phos-
phorylation sites located in two actin-binding regions
demonstrate specific kinase-dependent phosphorylation
changes. Threonine-180 and serine-185, which are located
in the CNR, exhibited significantly increased phosphoryl-
ation exclusively under the PKC activation conditions.
Serine-163, which is located in the ABS, exhibited solely
PKA-dependent phosphorylation changes. The direct in-
volvement of these two regions during actin binding has
been previously demonstrated by functional analyses of
transgelin2 homologues. Because the CNR was more im-
portant than the ABS with regard to the actin binding,
substantial phosphorylation changes of the CNR under
PKC activation conditions could effectively attenuate any
interactions between transgelin2 and cytoskeletal actin.
These results suggest that different actin binding capabil-
ities or two conflicting cellular functions of transgelin2
may be meticulously controlled by specific kinase cascades
activated under immune response activation or immune
response homeostasis conditions. Finally, our specific pro-
tein quantitative phosphorylation analysis method which
can monitor the phosphorylation changes of individual
phosphorylation sites under any specific kinase activation
conditions is especially useful for functional validation of
protein phosphorylation because more than one type of
protein kinases is likely to be involved in regulating the
functional state of a target protein.
Methods
Reagents
HPLC grade acetonitrile (ACN), methanol, water and
BCA Protein assay kit were purchased from Fisher Sci-
entific (Fair Lawn, NJ, USA). Fetal bovine serum (FBS),
Geneticin (G418) and RPMI medium 1640 were pur-
chased from GIBCO (Auckland, N.Z.). Pro-Q Diamond
phosphoprotein gel staining kit was purchased from Mo-
lecular Probes (Eugene, OR, USA). Rabbit polyclonalanti-GFP was developed in rabbit by using purified re-
combinant full-length GFP protein (AbFrontier). All
other chemicals were obtained from Sigma (St. Louis,
MO, USA).
Cell culture, Transfection and Phosphatase Inhibitor
treatments
Jurkat T cells were transiently transfected with cDNAs
encoding GFP-tagged transgelin2 by Nucleofector Kit V
(Amaxa) according to manufacturer’s instructions and
then selected with 1 mg/mL Geneticin. Jurkat T cells
(TIB-152, American Type Culture Collection) trans-
fected with GFP-tagged transgelin2 were grown in RPMI
1640 medium supplemented with 10% FBS and 1% peni-
cillin/streptomycin at 37°C. Jurkat T cells expressing
GFP-tagged transgelin2 were grown to confluence and
then subjected to serum deprivation for 18 h. These cells
were subjected to each of the following treatment condi-
tions. No-activation condition samples were untreated
or treated with 100 nM calyculin A (LC Laboratories),
or 1 μM okadaic acid for 30 min prior to cell harvest.
PKA activation condition was induced by 100 nM for-
skolin and PKC activation was induced by 200 nM phor-
bol 12-myristate 13-acetate (PMA) for 30 min. Two
protein kinase activation condition samples were then
treated with 100 nM calyculin A for 30 min prior to cell
harvest.
Cell lysis, Immuno-precipitation, SDS PAGE and In-gel
digestion
No activation and kinase activation (PKA or PKC) cells
were washed and harvested with cold phosphate buff-
ered saline (PBS). The pellets were resuspended in lysis
buffer (1% Nonidet P-40, 50 mM Tris–HCl pH 8.0,
150 mM NaCl and 2 mM EDTA) with protease inhibitor
cocktail (Roche) and phosphatase inhibitor cocktail
(Roche). The lysates were centrifuged at 13000 rpm for
10 min. The supernatant was transferred to a new tube.
For immune-precipitation experiments, the immune
complexes containing 5 mg proteins and anti-GFP con-
jugated Sepharose 4B (GE Healthcare) were gently
mixed for overnight at 4°C and then washed twice with
lysis buffer. Eluted proteins by heating of the beads at
95°C for 10 min in Laemmli SDS-PAGE sample buffer
were separated by 10% SDS-PAGE. For phospho-specific
fluorescent staining, all gels were treated with fixation
solution (3 × 30 min), washed with deionized water (3 ×
10 min), and stained with Pro-Q Diamond staining solu-
tion for 90 min. After Pro-Q Diamond staining, gels were
imaged using a FLA-7000 imaging analyzer (Fujifilm). Fol-
lowing scanning of Pro-Q Diamond-stained gels, the gels
were also stained with Coomassie Brilliant Blue (CBB)
R250. The gel pieces were subjected to in-gel digestion as
described previously [29]. For linearity experiments, various
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0.1 to 1.0 μg were added to the SDS-PAGE separation.
IMAC phosphopeptide enrichment
A fused-silica capillary (250 μm i.d. × 360 μm o.d., Polymi-
cro Technologies) was packed with 3 cm of 5 μm 120 Å
ReproSil Pur Aqua C18 (Phenomenex) using a high-
pressure Bomb for desalting purposes. The tryptic digest
samples were loaded onto the column at a flow rate of
2 μL/min. The column was washed with 1 mL of 1% formic
acid and 120 μL of IMAC binding buffer (40% ACN, 0.1%
formic acid) was used to elute peptides. PHOS-Select iron
affinity gel (15 μL of 50% beads slurry) was incubated with
the desalted peptides for 1 hr at room temperature. After
beads were washed with 1 mL of the IMAC binding buffer,
bound phosphopeptides were eluted using 200 μL of IMAC
elution buffer (200 mM NH4H2PO4) and the resulting
phosphopeptide samples were analyzed by micro RPLC-
MS/MS. Micro RPLC-MS/MS analyses were carried out
only once for each phosphopeptide-enriched sample to
show reproducibility of our label-free quantitative phos-
phorylation analysis.
Micro RPLC-MS/MS analysis
Micro RPLC-MS/MS analysis was performed using an Agi-
lent 1100 series high performance liquid chromatography
(HPLC) pump (Agilent Technologies) coupled to a linear
ion trap mass spectrometer (LTQ, Thermo Finnigan, San
Jose, CA, USA) with an in-house manufactured nano-ESI
interface. For micro RPLC-MS/MS analysis, samples were
injected into a trap column (fused-silica capillary 250 μm i.
d. × 360 μm o.d.; packed with 2 cm of Aqua C18) and sepa-
rated with an analytical column (fused-silica capillary
100 μm i.d. × 360 μm o.d.; packed with 7.5 cm of Aqua
C18). Buffer A (0.1% FA) and Buffer B (80% ACN, 0.1% for-
mic acid) were used to elute bound peptides with a split
flow system (flow rate: 250 nL/min) for 120 min linear gra-
dient. In a positive ion mode, spectra were acquired with
cycles of one full MS scan in the LTQ (m/z 400–2000)
followed by 10 data-dependent MS/MS scans with normal-
ized collision energy of 35% and dynamic exclusion time of
30 s.
Data analysis
MS/MS spectra were searched against in-house database
containing various transgelin2 homologues, GFP, IgG se-
quences and bovine alpha casein sequences using
SEQUEST algorithm (Bioworks 3.2). Methionine oxida-
tion and phosphorylation of serine, threonine, and tyro-
sine as variable modifications and carbamidomethylation
of cysteine as a fixed modification were applied to the
search. DTAselect (v.1.9) was used to filter the search re-
sults with the following criteria: fully tryptic digest ends,
Xcorr > 1.8 for charge state 1+, Xcorr > 2.5 for chargestate 2+ and Xcorr > 3.5 for charge state 3+. Assign-
ments of the phosphopeptide sequences were further
confirmed by manual validations on filtered MS/MS
spectra. For the quantification of phosphorylation levels,
selected ion chromatograms of identified phosphopep-
tides were constructed using Xcalibur 2.1.0 SP1 program
(Thermo) and integrated peak areas were then calculated
with a built-in feature of Xcalibur program for comparison
purposes. Relative quantification of each phosphopeptide
was performed by comparing peak-areas of no-activation
condition and those of two kinase activation condition
samples. Student’s t test was used for statistical analysis be-
tween no-activation condition and two kinase activation
condition samples.
Additional files
Additional file 1: Figure S1. Manually assigned MS/MS spectrum of a
phosphopeptide containing threonine-84.
Additional file 2: Table S1. Label-free quantitative phosphorylation
analysis results of transgelin2 from three independent experiments. All
peak areas were normalized to the co-added alpha casein tryptic digest
peptide in the sample preparation.
Additional file 3: Figure S2. Linearity of label-free quantitative
phosphorylation analysis. Various concentrations of bovine alpha casein
samples ranging from 0.1 to 1.0 μg were added in SDS-PAGE separation.
Three independent experiments were performed and peak areas of
individual alpha casein phosphopeptides were plotted against loaded
amounts of alpha casein.
Additional file 4: Figure S3. PKC-dependent phosphorylation changes
of transgelin2 serine-11. Selected ion chromatograms of serine-11
containing phosphopeptide under no activation (A) and PKC activation
(B) conditions. Manually assigned MS/MS spectrum of phosphopeptide
containing serine-11 (C).
Additional file 5: Figure S4. PKC dependent phosphorylation changes of
transgelin2 threonine-180. Selected ion chromatograms of threonine-180
containing phosphopeptide under no activation (A) and PKC activation (B)
conditions. Manually assigned MS/MS spectrum of phosphopeptide
containing threonine-180 (C).
Additional file 6: Figure S5. PKA-dependent phosphorylation
changes of transgelin2 serine-163. Selected ion chromatograms of a
phosphopeptide containing serine-163 under no activation (A) and PKA
activation (B) conditions. Manually assigned MS/MS spectrum of
phosphopeptide containing serine-163 (C).
Additional file 7: Figure S6. Label-free relative quantitative
phosphorylation analysis results of transgelin2 phosphorylation site
(ser-185) under PKA and PKC activation conditions. * denotes the level of
statistically significant difference in three independent sets of
experiments. (p < 0.05).
Additional file 8: Figure S7. Sequence alignment analysis results of
transgelin2 and calponin1 using Protein BLAST feature from the PubMed
website (www.ncbi.nlm.nih.gov/pubmed/).
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